The Role of Palliative Chemotherapy in Hospitalized Patients
Paul Wheatley‐Price(University of Ottawa), C. Cripps(Canadian Partnership Against Cancer), Jennifer C. Spencer(Decision Sciences (United States)), Katelyn Balchin(Ottawa Hospital), Maria Ali(University of Ottawa), Edward Fitzgibbon(University of Ottawa)
Cited by 44
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
|The Lancet Oncology|2018|1k
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
|The Lancet Oncology|2018|579
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
|Journal of Clinical Oncology|2016|291
Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144
|Journal of Clinical Oncology|2006|167